Status:
COMPLETED
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
Lead Sponsor:
Novartis
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication.
Eligibility Criteria
Inclusion
- Patients with mild to moderate hypertension
Exclusion
- Severe hypertension
- History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
- Liver, kidney, or pancreas disease
- Insulin dependent diabetes
- Allergy to certain medications used to treat high blood pressure
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
2714 Patients enrolled
Trial Details
Trial ID
NCT00170989
Start Date
September 1 2004
End Date
July 1 2005
Last Update
November 8 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigative Centers, Germany
2
Novartis Pharmaceuticals
Basel, Switzerland